| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Zinc | Alcoholic Liver Disease | 4 | PM | 19376089 | 📋 | Zinc supplementation attenuates ethanol- and acetaldehyde-induced liver stellate cell activation by inhibiting reactive oxygen species (ROS) production and by influencing intracellular signaling |
| Zinc | Alcoholic Liver Disease | 2 | PM | 18375824 | 📋 | Zinc supplementation inhibits hepatic apoptosis in mice subjected to a long-term ethanol exposure |
| Zinc | Alcoholic Liver Disease | 3 | PM | 16099027 | 📋 | Zinc prevention and treatment of alcoholic liver disease |
| Zinc | Alcoholic Liver Disease | 1 | PM | 15920153 | 📋 | Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress |
| Zinc | Hepatic Cirrhosis | 4 | PM | 37189711 | 📋 | Biological Role of Zinc in Liver Cirrhosis: An Updated Review |
| Zinc | Hepatic Cirrhosis | 1 | PM | 25280421 | 📋 | Effect of zinc on liver cirrhosis with hyperammonemia: a preliminary randomized, placebo-controlled double-blind trial |
| Zinc | Hepatic Cirrhosis | 2 | PM | 19902019 | 📋 | Zinc supplementation improves the outcome of chronic hepatitis C and liver cirrhosis |
| Zinc | Hepatic Cirrhosis | 3 | PM | 19376089 | 📋 | Zinc supplementation attenuates ethanol- and acetaldehyde-induced liver stellate cell activation by inhibiting reactive oxygen species (ROS) production and by influencing intracellular signaling |
| Zinc | Hepatic Encephalopathy | 2 | PM | 34582657 | 📋 | Efficacy of Zinc Supplement in Minimal hepatic Encephalopathy: A prospective, Randomized Controlled Study (Zinc-MHE Trial) |
| Zinc | Hepatic Encephalopathy | 1 | PM | 33242359 | 📋 | Zinc deficiency predicts overt hepatic encephalopathy and mortality in liver cirrhosis patients with minimal hepatic encephalopathy |
| Zinc | Hepatic Fibrosis | 2 | PM | 33095789 | 📋 | Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease |
| Zinc | Hepatic Fibrosis | 1 | PM | 19376089 | 📋 | Zinc supplementation attenuates ethanol- and acetaldehyde-induced liver stellate cell activation by inhibiting reactive oxygen species (ROS) production and by influencing intracellular signaling |
| Zinc | Hepatitis A | 1 | PM | 33144437 | 📋 | Additive Effects of Zinc Chloride on the Suppression of Hepatitis A Virus Replication by Interferon in Human Hepatoma Huh7 Cells |
| Zinc | Hepatitis B | 1 | PM | 36381223 | 📋 | The relationship between zinc deficiency and infectious complications in patients with hepatitis B virus-related acute-on-chronic liver failure |
| Zinc | Hepatitis C | 5 | PM | 34623551 | 📋 | IL28B rs12979860 polymorphism and zinc supplementation affect treatment outcome and liver fibrosis after direct-acting antiviral hepatitis C therapy |
| Zinc | Hepatitis C | 4 | PM | 23170044 | 📋 | Zinc supplementation therapy improves the outcome of patients with chronic hepatitis C |
| Zinc | Hepatitis C | 1 | PM | 19902019 | 📋 | Zinc supplementation improves the outcome of chronic hepatitis C and liver cirrhosis |
| Zinc | Hepatitis C | 2 | PM | 17874825 | 📋 | Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin |
| Zinc | Hepatitis C | 3 | PM | 11555194 | 📋 | Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C |
| Zinc | Hepatotoxicity | 4 | PM | 37676925 | 📋 | Selenium and zinc alleviate hepatotoxicity induced by heavy metal mixture (cadmium, mercury, lead and arsenic) via attenuation of inflammo-oxidant pathways |
| Zinc | Hepatotoxicity | 2 | PM | 31532279 | 📋 | Zinc abrogates anticancer drug tamoxifen-induced hepatotoxicity by suppressing redox imbalance, NO/iNOS/NF-ĸB signaling, and caspase-3-dependent apoptosis in female rats |
| Zinc | Hepatotoxicity | 1 | PM | 31199767 | 📋 | Role of antioxidant supplementation in oxidant/antioxidant status and hepatotoxic effects due to aflatoxin B1 in wheat miller workers |
| Zinc | Hepatotoxicity | 3 | PM | 18375824 | 📋 | Zinc supplementation inhibits hepatic apoptosis in mice subjected to a long-term ethanol exposure |
| Zinc | Liver Cancer | 1 | PM | 34752016 | 📋 | Oral Zinc Supplementation Decreases the Risk of HCC Development in Patients With HCV Eradicated by DAA |
| Zinc | Liver Damage | 4 | PM | 34307690 | 📋 | Zinc Supplementation Prevented Type 2 Diabetes-Induced Liver Injury Mediated by the Nrf2-MT Antioxidative Pathway |
| Zinc | Liver Disease | 1 | PM | 34614431 | 📋 | Zinc supplementation and its benefits in the management of chronic liver disease: An in-depth literature review |
| Zinc | MAFLD | 4 | PM | 38012749 | 📋 | The effects of zinc supplementation on the metabolic factors in patients with non-alcoholic fatty liver disease: a randomized, double-blinded, placebo-controlled clinical trial |
| Zinc | MAFLD | 3 | PM | 34337376 | 📋 | The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease |
| Zinc | MAFLD | 2 | PM | 33095789 | 📋 | Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease |
| Zinc | MAFLD | 1 | PM | 32939643 | 📋 | Zinc Supplementation and Strength Exercise in Rats with Type 2 Diabetes: Akt and PTP1B Phosphorylation in Nonalcoholic Fatty Liver |
| Zinc | Non-Alcoholic Steatohepatitis | 1 | PM | 37989929 | 📋 | Effects of Zinc Supplementation on Inflammatory Status and Nonalcoholic Steatohepatitis in Overweight or Obese Children: a Randomized Clinical Trial |
| Zinc | Wilson's Disease | 2 | PM | 32809015 | 📋 | Combined dimercaptosuccinic acid and zinc treatment in neurological Wilson's disease patients with penicillamine-induced allergy or early neurological deterioration |
| Zinc | Wilson's Disease | 1 | PM | 16793346 | 📋 | Resolution of decompensated cirrhosis from Wilson's disease with zinc monotherapy: a potential therapeutic option? |
